Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Colorectal cancer (CRC) is currently the third leading cause of cancer-related mortality, with 1.9 million incidence cases and 0.9 million deaths worldwide. The global number of new CRC cases is predicted to reach 3.2 million in 2040, based on the projection of aging, population growth, and human development. In clinics, despite advances of diagnosis and surgical procedures, 20% of the patients with CRC present with metastasis at the time of diagnosis, caused by residual tumor cells that have spread to distant organs prior to surgery, affecting the patient survival rate. Standard systemic chemotherapy, alternative therapies that target mechanisms involved in cancer progression and metastasis, immunotherapy, and combination therapies are the major CRC-treatment strategies. In the advanced stage of CRC the transforming growth factor-beta (TGF-β) plays an oncogenic role by promoting cancer cell proliferation, cancer cell self-renewal, epithelial-to-mesenchymal transition, invasion, tumor progression, metastatic spread, and immune escape. Furthermore, high levels of TGF-β1 confers poor prognosis and is associated with early recurrence after surgery, resistance to chemo- or immunotherapy, and shorter survival. Based on the body of experimental evidence indicating that TGF-β signaling has the potential to be a good therapeutic target in CRC, several anti-TGF-β drugs have been investigated in cancer clinical trials. Here, we presented a comprehensive collection of manuscripts regarding studies on targeting the TGF-β signaling in CRC to improve patient's prognosis and personalized treatments.

Rectum --- Cancer. --- Colorectal cancer --- Rectal cancer

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Fast Facts: Colorectal Cancer delivers concise and highly practical information on all aspects of this all too common disease. It provides invaluable information for the primary care team, who are key to the screening and diagnosis of the disease.

Colon (Anatomy) --- Rectum --- Cancer. --- Colorectal cancer --- Rectal cancer --- Colon cancer

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Rectum --- Colon (Anatomy) --- Cancer. --- Colon cancer --- Colorectal cancer --- Rectal cancer

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Colon (Anatomy) --- Rectum --- Cancer. --- Colorectal cancer --- Rectal cancer --- Colon cancer

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

This book provides an up-to-date and detailed overview of diagnostic and management strategies for rectal cancer. It includes chapters focusing on recent diagnostic modalities such as technical advances, the role of magnetic resonance imaging (MRI), immunology, and histopathology, as well as the latest surgical techniques for the management of rectal cancer. It also discusses the role of adjuvant, neo-adjuvant and non-operative approaches. Further, it presents the recent guidelines of prevention and early diagnosis, as well as current and future diagnostic and staging work-up, clearly and concisely, linking each topic to the therapeutic options arising from the staging. A large part of this multifaceted book is devoted to the in-hospital care of rectal cancer patients, from the fast-track procedures and enhanced recovery systems to detailed descriptions of the available surgical techniques, including salvage situations, accidents, complications and their treatment.

Oncology  . --- Surgery. --- Oncology. --- Rectum --- Cancer. --- Colorectal cancer --- Rectal cancer --- Surgery, Primitive --- Medicine --- Tumors